-
(106-16) A Pilot Multi-Arm Study of sEphB4-HSA In Combination with Different
Chemotherapy Regimens in Patients with Specific Advanced or Metastatic
Solid Tumors (Phase 1 clinical trial, appropriate for patients with metastatic cancers
of the bile duct, gallbladder; head and neck; non-small cell lung; and
pancreas.)
-
(114-17) Radiation Therapy With or Without Chemotherapy in Treating Patients
With High-Risk Malignant Salivary Gland Tumors That Have Been Removed
By Surgery (Phase 3 clinical trial, appropriate for patients with salivary gland tumors.)
-
(131-17) A Phase 1/2 Safety Study of Intratumorally Administered INT230-6
in Adult Subjects with Advanced Refractory Cancers (Phase 1 clinical trial, appropriate for patients with solid tumors.)
-
(134-17) A Phase IIa trial of sEphB4-HSA in combination with Anti PD-1
Antibody (Pembrolizumab, MK-3475) in patients with non-small cell lung
and head/neck cancer (Phase 2 clinical trial, appropriate for patients with lung, head or neck cancer.)
-
(157-17) FID-007 in Treating Participants With Advanced Solid Tumors (Phase 1 clinical trial, appropriate for patients with advanced solid
malignancies.)
- (167-17) Caris ctDNA Validation Project (Research study, appropriate for
patients with all solid tumors.)
-
(211-17) Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate
Hepatic Impairment Patients (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)
-
(214-17) A Phase 1/2 First-in-human Study of BMS-986258 Alone and in Combination
with Nivolumab in Advanced Malignant Tumors (Phase 1/2 clinical trial, appropriate for patients with advanced malignant tumors.)